Rochester Clinical Research is enrolling healthy adults ages 50–64 for a COVID-19 vaccine research study (non-mRNA).
This study is enrolling at both Buffalo & Rochester locations.
COVID Vaccine – Rochester
Age Range:
50 to 64
Gender:
Male and Female
Location:
Rochester, New York
About the Study
- Single study vaccination on Day 0, then health check-ins through ~6 months to monitor safety and effectiveness.
- Visit schedule: a screening visit and a vaccination visit, with scheduled follow-ups through 6 months (your exact office and check-in schedule will be confirmed at screening).
Qualifications
You may qualify if you are:
- Between the ages of 50 to 64 at the time of vaccination.
- Generally healthy (not considered at high risk for severe COVID-19).
* Other qualifications may apply.
FEATURED STUDIES
Adults 18 and older with obstructive sleep apnea (OSA) and overweight or obesity may qualify for a clinical study evaluating […]
Rochester Clinical Research is seeking adults to participate in a research study evaluating an investigational medication for nerve pain caused […]
Adults 65 years and older may qualify for a study evaluating an investigational vaccine designed to help prevent C. difficile […]
Rochester Clinical Research is enrolling healthy adults ages 50–64 for a COVID-19 vaccine research study (non-mRNA). This study is enrolling […]
Rochester Clinical Research is currently enrolling adults for a research study evaluating a once-weekly injection for people with knee pain […]
Adults 18 to 80 years of age may qualify for a study evaluating an investigational treatment for irritable bowel syndrome […]